This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2016
AUA 2016
- Prostate Cancer
- GU Reconstruction
- Penile Cancer
- Female Urology
- Releases
- CRPC w/ bone metastases
- Bladder cancer
- Renal Cancer
- Testicular cancer
- Stone disease
- Laparoscopic/Robotic/Technology
- BPH/LUTS
- Pelvic Pain/IC
- Voiding dysfunction
- Infections
AUA 2016 - Bladder cancer
Viewing 1-20 of 24 articles
AUA 2016: The Changing Face of Readmissions: Assessing the Impact of a Cystectomy Care Pathway - Session Highlights
AUA 2016: Enhanced Recovery after Surgery and Radical Cystectomy: Benefits of a Multidisciplinary Approach - Session Highlights
AUA 2016: Does enhanced recovery impact complications after radical cystectomy? - Session Highlights
AUA 2016: Racial disparities in quality metrics of muscle invasive bladder cancer - Session Highlights
AUA 2016: The Optimal Antibiotic Prophylaxis for Radical Cystectomy: a population-based analysis - Session Highlights
AUA 2016: A Phase I/II Trial of Prehabilitation in Patients Undergoing Cystectomy for Bladder Cancer - Session Highlights
AUA 2016: Long-term 10-year health-related quality of life outcomes following radical cystectomy - Session Highlights
AUA 2016: Prophylactic Antibiotics in the First 30 Days Following Radical Cystectomy with Urinary Diversion Leads to Fewer Urinary Tract Infections - Session Highlights
AUA 2016: Progression from Non-Muscle Invasive Bladder Cancer (NMIBC) to Muscle Invasion is Associated with Lower Response Rates to Neoadjuvant Chemotherapy - Session Highlights
AUA 2016: Is There Any Role for Adjuvant Chemotherapy or Novel Targeted Agents After Radical Cystectomy? - Session Highlights
AUA 2016: What To Do With BCG Refractory NMIBC When Cystectomy is Not an Option - Session Highlights
AUA 2016: Selection of TI Patients for Initial Cystectomy - Session Highlights
AUA 2016: What’s so Difficult about A New Approach Post-BCG? - Session Highlights
AUA 2016: Contemporary utilization trends of systemic chemotherapy for Upper Tract Urothelial Carcinoma (UTUC) - Poster Session Highlights
AUA 2016: Moderate chronic kidney disease (eGFR n bladder cancer patients treated with transurethral resection - Session Highlights
AUA 2016: Predictors of Genitourinary Malignancy Among Patients with Primary Microscopic Hematuria - Session Highlights
AUA 2016: Assessing the relative contribution of hospital and surgeon volume on short term mortality outcomes following radical cystectomy - Session Highlights
AUA 2016: Improving radical cystectomy care: outcomes, compliance, and barriers to adoption for a new protocol - Session Highlights
AUA 2016: Trends in Regionalization of Care and Mortality for Patients Treated with Radical Cystectomy - Session Highlights
AUA 2016: Anti-PDL and anti-PDL-1 trials in bladder cancer - Session Highlights
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free